CDC37 as a novel target for the treatment of NPM1-ALK expressing anaplastic large cell lymphomas.

Sudhakiranmayi KuraviElizabeth ParrottGiridhar MudduluruJanice ChengSiddhartha GangulyYogen SaunthararajahRoy A JensenBrian S BlaggJoseph P McGuirkRamesh Balusu

Published in: Blood cancer journal (2019)

Keyphrases

acute myeloid leukemia
single cell
cell therapy
combination therapy
cell proliferation
tyrosine kinase
wild type